Marlborough UK Multi-Cap Growth Fund Class P Inc
Rated Fund 2017-2018. Good pick for investors wanting broad spread
For investors who want a bit of everything, this fund provides a way to invest in companies of any size that offer good growth prospects.
Launched in 1995, it was originally called the Marlborough UK Leading Companies fund, but was rebranded in 2014 to reflect the fact that it invests across the size spectrum of UK companies.
Richard Hallett, the manager since 2005, looks for companies that have a sustainable competitive advantage that they can use to raise prices and/or take market share. The fund typically has around 50 holdings.
Hallett seeks out businesses with a competitive edge, which could come from the quality of their management, branding, sales and marketing, product innovation, research and development, or intellectual property. However, he says it is often a combination of these factors.
He particularly likes businesses that can grow throughout the market cycle, with limited need for capital expenditure and high levels of free cash flow to invest in further growth. He tends to steer clear of commodities, construction and biotech companies and avoids businesses with low barriers to entry, such as contractors, consultancies and recruitment companies. Instead, he often favours consumer services, industrial and technology stocks.
The manager's primary focus is on stock-picking as he feels markets are impossible to call. This means he tends to avoid cyclical businesses and prefers companies benefiting from structural change or established long-term trends. Typically, the fund holds 40 per cent in large companies, 40 per cent in medium companies and 20 per cent in smaller companies.
Narrative and ratings content all as of 01 January 2018.See all Money Observer rated funds
|Burford Capital Ltd||3.16 %|
|Homeserve PLC||3.13 %|
|Worldpay Inc Class A||2.81 %|
|Scottish Mortgage Ord||2.65 %|
|Prudential PLC||2.60 %|
|Craneware PLC||2.58 %|
|Fevertree Drinks PLC||2.58 %|
|Abcam PLC||2.56 %|
|Dechra Pharmaceuticals PLC||2.54 %|
|NMC Health PLC||2.54 %|
|United Kingdom||90.09 %|
|United States||6.07 %|
|Financial Services||18.75 %|
|Consumer Cyclical||11.58 %|
|Basic materials||10.28 %|
|Consumer Defensive||6.03 %|
Richard qualified as a Chartered Accountant at Ernst & Young in 1994 and subsequently joined Singer & Friedlander in 1995 as a UK Equity fund manager. Since joining the investment team in 2005, Richard has established a strong and consistent track record as manager of the Marlborough UK Multi-Cap Growth Fund.
Data provided by Morningstar.
The Content is only for your general information and use and is not intended to address your particular requirements. The Content does not constitute any form of advice, recommendation or arrangement by Money Observer and is not intended to be relied upon by you in making (or refraining from making) any specific investment or other decisions. Appropriate independent advice should be obtained before making any such decision.
This information is sourced from our partner Morningstar. We believe the data to be correct however you should take care in using any information.
You should be aware that prices may fall as well as rise and that the income derived can go down as well as up. When buying or selling any investment that fluctuates in price or value you may get back less than you invested. Past performance is not necessarily a guide to future performance.